Safety and Efficacy of an Antibody to CCR5 in Individuals With HIV Who Are Not Currently on Antiretroviral Therapy

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2005

Study Completion Date

April 30, 2006

Conditions

HIV Infections

Interventions

DRUG

CCR5mAb004

Trial Locations (7)

AIDS Research Alliance, Los Angeles

Quest Clinical Research, San Francisco

Fort Lauderdale

The Orlando Immunology Center, Orlando

Johns Hopkins Hospital, Baltimore

University Hospitals of Cleveland, Cleveland

OSU Medical Center, Columbus